Kenta Haraya

10PUBLICATIONS
15CO-AUTHORS
Biomolecular modelling and designMedical molecular engineering of nucleic acids and proteinsGene and molecular therapyRegenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 31, 2026
Human Pharmacokinetic Prediction of Antibody-Drug Conjugates Using Human FcRn Transgenic Mice.

|Jan 22, 2026
Quantitative Prediction of Human Pharmacokinetics for Fc-Engineered Therapeutic Monoclonal Antibodies With Increased FcRn Binding Mutations After Subcutaneous Injection.

Kenta Haraya, Taichi Kuramochi

|Mar 25, 2025
Prediction of human pharmacokinetics of Fc-engineered therapeutic monoclonal antibodies using human FcRn transgenic mice.

Kenta Haraya, Takuya Ichikawa, Naoaki Murao

|Nov 09, 2024
Beyond Recycling Antibodies: Crovalimab's Molecular Design Enables Four-Weekly Subcutaneous Injections for PNH Treatment.

Zenjiro Sampei, Kenta Haraya, Siok Wan Gan

|Jun 20, 2023
Efficient production of bispecific antibody by FAST-IgTM and its application to NXT007 for the treatment of hemophilia A.

Hikaru Koga, Takashi Yamano, Juan Betancur

|Nov 30, 2022
Translational Approach for Predicting Human Pharmacokinetics of Engineered Therapeutic Monoclonal Antibodies with Increased FcRn-Binding Mutations.

Kenta Haraya, Tatsuhiko Tachibana

Pageof 2

Frequent Collaborators

2 joint publications

Zenjiro Sampei

1 joint publications

Taiji Miyake

1 joint publications

Tatsuhiko Tachibana

1 joint publications

Yasuhiro Kazuki